(Q87725466)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752729%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

title

The type 1 diabetes resistance locus B10 Idd9.3 mediates impaired B-cell lymphopoiesis and implicates microRNA-34a in diabetes protection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752729%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

1 reference

Gregory J Berry

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752729%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Lynn R Budgeon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752729%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Timothy K Cooper

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752729%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Neil D Christensen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752729%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Hanspeter Waldner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752729%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

publication date

29 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752729%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

15 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752729%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752729%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752729%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

page(s)

1716-1727

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752729%20AND%20SRC:MED&resulttype=core&format=json

Genetics, pathogenesis and clinical interventions in type 1 diabetes

15 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

The NOD mouse: a model of immune dysregulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Mechanism underlying counterregulation of autoimmune diabetes by IL-4.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Following a diabetogenic T cell from genesis through pathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

B cell-directed therapies in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Gene-gene interactions in the NOD mouse model of type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Idd9.2 and Idd9.3 protective alleles function in CD4+ T-cells and nonlymphoid cells to prevent expansion of pathogenic islet-specific CD8+ T-cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Idd9.1 locus controls the suppressive activity of FoxP3+CD4+CD25+ regulatory T-cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Idd9/11 genetic locus regulates diabetogenic activity of CD4 T-cells in nonobese diabetic (NOD) mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

The autoimmune diabetes locus Idd9 regulates development of type 1 diabetes by affecting the homing of islet-specific T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

The B10 Idd9.3 locus mediates accumulation of functionally superior CD137(+) regulatory T cells in the nonobese diabetic type 1 diabetes model.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Foxp1 is an essential transcriptional regulator of B cell development

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Genetic and functional association of the immune signaling molecule 4-1BB (CD137/TNFRSF9) with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Peripheral development of B cells in mouse and man.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Peripheral B cell subsets

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Cutting edge: impaired transitional B cell production and selection in the nonobese diabetic mouse.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Characterization of marginal zone B cell precursors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

MicroRNAs: target recognition and regulatory functions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Downregulation of FOXP1 is required during germinal center B-cell function.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Genetic control of anti-Sm autoantibody production in NOD congenic mice narrowed to the Idd9.3 region.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Systemic autoimmunity in BAFF-R-mutant A/WySnJ strain mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Effector and regulatory B cells: modulators of CD4+ T cell immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Investigation of the role of B-cells in type 1 diabetes in the NOD mouse

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Loss of intra-islet CD20 expression may complicate efficacy of B-cell-directed type 1 diabetes therapies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Subcongenic analyses reveal complex interactions between distal chromosome 4 genes controlling diabetogenic B cells and CD4 T cells in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344116

7 January 2021

Identifiers

DOI

10.1002/EJI.201344116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752729%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

1 reference